Hyperfine Inc
NASDAQ:HYPR
Hyperfine Inc
Cash Equivalents
Hyperfine Inc
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Hyperfine Inc
NASDAQ:HYPR
|
Cash Equivalents
$37.6m
|
CAGR 3-Years
-42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash Equivalents
$711m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-22%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash Equivalents
$2.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
63%
|
CAGR 10-Years
16%
|
|
|
Stryker Corp
NYSE:SYK
|
Cash Equivalents
$3.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
7%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash Equivalents
$7.6B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
15%
|
CAGR 10-Years
6%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash Equivalents
$8.8B
|
CAGR 3-Years
131%
|
CAGR 5-Years
64%
|
CAGR 10-Years
31%
|
|
Hyperfine Inc
Glance View
Hyperfine, Inc. is a medical device development company, which engages in providing imaging and monitoring through magnetic resonance imaging to revolutionize healthcare for people. The company is headquartered in Guilford, Connecticut and currently employs 136 full-time employees. The company went IPO on 2021-01-27. The firm provides a Swoop system, which is a portable magnetic resonance imaging (MRI) system capable of providing neuroimaging at the point of care. Its Swoop Portable Magnetic Resonance Imaging System (Swoop system) produces images at a lower magnetic field strength than conventional MRI scanners. MRI is a medical imaging technique used in radiology to image the human body’s anatomy and physiological processes. MRI is used in various clinical settings for medical diagnosis, the staging of disease, and follow-up treatment. The company designed its Swoop system to address an unmet need in point-of-care medical imaging through a combination of hardware and Artificial intelligence (AI)-powered software services. Its hardware uses modern computational power and deep learning advances. Its software addresses the traditional ease-of-use and integration challenges often presented by specialized medical technologies.
See Also
What is Hyperfine Inc's Cash Equivalents?
Cash Equivalents
37.6m
USD
Based on the financial report for Dec 31, 2024, Hyperfine Inc's Cash Equivalents amounts to 37.6m USD.
What is Hyperfine Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 3Y
-42%
Over the last year, the Cash Equivalents growth was -50%. The average annual Cash Equivalents growth rates for Hyperfine Inc have been -42% over the past three years .
You don't have any saved screeners yet